Clinical Trials in Zurich, Canton of Zurich
136 recruiting
Showing 1–20 of 128 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled288 locationsNCT06393374
Recruiting
Not Applicable
Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support Just-in-Time Adaptive Intervention
Depressive SymptomsLonelinessSocial Support
University of Zurich120 enrolled1 locationNCT07471529
Recruiting
Not Applicable
Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training
Mild Cognitive ImpairmentParkinson's Disease
University of Zurich50 enrolled1 locationNCT07441915
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801
Recruiting
Not Applicable
Functional Near-infrared Spectroscopy in Unconscious Patients
Nervous System DiseasesHealthy Subjects
Emanuela Keller30 enrolled2 locationsNCT04746820
Recruiting
Phase 4
SWIFT - SWIss Factor XIII Trial in PPH
Postpartum ComplicationCoagulation DisorderPostpartum Hemorrhage+2 more
Christian Haslinger988 enrolled9 locationsNCT06481995
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy
ThrombectomyAcute Cerebrovascular AccidentCerebral Revascularization
University of Zurich100 enrolled1 locationNCT07534319
Recruiting
Not Applicable
Emotional-distress-based Integrated Care Programme in Patients With Stable COPD
COPD
University of Zurich15 enrolled1 locationNCT07524023
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled258 locationsNCT06312176
Recruiting
Clinical and Histological Study of a Novel Dermal Substitute
Skin Transplantation
University Children's Hospital, Zurich42 enrolled4 locationsNCT06255990
Recruiting
Phase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
AbbVie540 enrolled254 locationsNCT06548542
Recruiting
Not Applicable
Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease
Lung BiopsyInterstitial Lung Disease (ILD)
University of Zurich30 enrolled2 locationsNCT07500818
Recruiting
Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder EmptyingAsymptomatic Bacteriuria in Subjects Relying on Some Type of CatheterRecurrent Non-catheter Associated UTIs+2 more
University of Zurich800 enrolled1 locationNCT07494864
Recruiting
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
AbbVie400 enrolled94 locationsNCT05496348
Recruiting
Not Applicable
Arrhythmogenic Activity During Exercise in ARVC Patients
Arrhythmogenic Right Ventricular Cardiomyopathy
Swiss Federal Institute of Technology120 enrolled1 locationNCT06040242
Recruiting
Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
AbbVie1,280 enrolled279 locationsNCT06468228
Recruiting
Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Central Nervous System TumorGlioblastomaCNS Tumor+5 more
Sabine Mueller, MD, PhD208 enrolled6 locationsNCT04732065
Recruiting
Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
AbbVie110 enrolled85 locationsNCT05995353
Recruiting
Not Applicable
Effect of Acute Hypoxia on RIght VEntRicular Function in Healthy Adults.
HypoxiaNormobaric HypoxiaAltitude Hypoxia+1 more
Mona Lichtblau18 enrolled2 locationsNCT07431567